PRINT | CLOSE WINDOW

Trulign lens by B&L gets FDA approval

By WILL ASTOR - 5/21/2013 3:08:15 PM

Bausch & Lomb Inc. has received U.S. Food and Drug Administration approval for its Trulign lens, company officials said Tuesday.

Meant for cataract and other eye-surgery patients, the Trulign lens corrects astigmatic blurred vision, which can be an unwanted side effect of artificial lens implantation.  According to the eye-care company, it is the first toric intraocular lens that can correct astigmatism and deliver improved vision across a natural range of focus as well.   
 
(c) 2013 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail service@rbj.net.